Short-Term Metformin Treatment Enriches Bacteroides dorei in an Obese Liver Steatosis Zucker Rat Model

Obesity is the leading cause of health-related diseases in the United States and World. Previously, we reported that obesity can change gut microbiota using the Zucker rat model. Metformin is an oral anti-hyperglycemic agent approved by the FDA to treat type 2 diabetes (T2D) in adults and children o...

Descripción completa

Detalles Bibliográficos
Autores principales: Robeson, Michael S., Manna, Kanishka, Randolph, Christopher, Byrum, Stephanie, Hakkak, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006818/
https://www.ncbi.nlm.nih.gov/pubmed/35432282
http://dx.doi.org/10.3389/fmicb.2022.834776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006818/
https://www.ncbi.nlm.nih.gov/pubmed/35432282
http://dx.doi.org/10.3389/fmicb.2022.834776

Ejemplares similares